ES2118242T3 - Vacunas anti virus de la inmunodeficiencia felina (fiv). - Google Patents

Vacunas anti virus de la inmunodeficiencia felina (fiv).

Info

Publication number
ES2118242T3
ES2118242T3 ES93915919T ES93915919T ES2118242T3 ES 2118242 T3 ES2118242 T3 ES 2118242T3 ES 93915919 T ES93915919 T ES 93915919T ES 93915919 T ES93915919 T ES 93915919T ES 2118242 T3 ES2118242 T3 ES 2118242T3
Authority
ES
Spain
Prior art keywords
ivf
viruses
feline immunodeficiency
vaccines anti
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93915919T
Other languages
English (en)
Inventor
Albertus Dominicus M Osterhaus
Cornelis Herman Joha Siebelink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ES2118242T3 publication Critical patent/ES2118242T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA MOLECULAS DE ACIDO NUCLEICO QUE CONTIENEN SECUENCIAS DE NUCLEOTIDO QUE SUSTANCIALMENTE CORRESPONDEN A LA TOTALIDAD O UNA PORCION DE LA REGION DEL GEN ENV DE VIF QUE CODIFICA RESIDUOS 483 A 567 DE LA PROTEINA QUE ENVUELVE EL VIF O UNA SECUENCIA QUE ESTA DEGENERADA, SUSTANCIALMENTE HOMOLOGA CON, O QUE HIBRIDA CON, CUALQUIERA DE TALES SECUENCIAS ANTES MENCIONADAS, SU USO EN LA PREPARACION DE VACUNAS CONTRA VIF, Y, POLIPEPTIDOS SINTETICOS CODIFICADOS POR ELLAS.
ES93915919T 1992-07-17 1993-07-15 Vacunas anti virus de la inmunodeficiencia felina (fiv). Expired - Lifetime ES2118242T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215232A GB9215232D0 (en) 1992-07-17 1992-07-17 Vaccines

Publications (1)

Publication Number Publication Date
ES2118242T3 true ES2118242T3 (es) 1998-09-16

Family

ID=10718887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93915919T Expired - Lifetime ES2118242T3 (es) 1992-07-17 1993-07-15 Vacunas anti virus de la inmunodeficiencia felina (fiv).

Country Status (11)

Country Link
EP (1) EP0651806B1 (es)
JP (2) JPH08500244A (es)
AT (1) ATE166390T1 (es)
AU (1) AU4569293A (es)
DE (1) DE69318716T2 (es)
DK (1) DK0651806T3 (es)
ES (1) ES2118242T3 (es)
GB (1) GB9215232D0 (es)
GR (1) GR3027636T3 (es)
WO (1) WO1994002612A1 (es)
ZA (1) ZA935117B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833993A (en) * 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
ES2327340T3 (es) 2003-09-11 2009-10-28 Idexx Laboratories, Inc. Procedimiento y dispositivo para detectar el virus de la inmunodeficiencia felina.
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7285272B2 (en) 2003-12-18 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005215629B2 (en) 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267608B2 (en) * 2004-06-30 2009-01-15 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (FIV) comprising the use of peptides derived from the V3 region of the FIV env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein

Also Published As

Publication number Publication date
EP0651806A1 (en) 1995-05-10
WO1994002612A1 (en) 1994-02-03
AU4569293A (en) 1994-02-14
JPH08500244A (ja) 1996-01-16
JP2009005706A (ja) 2009-01-15
DE69318716T2 (de) 1998-09-10
ZA935117B (en) 1994-02-08
DE69318716D1 (de) 1998-06-25
EP0651806B1 (en) 1998-05-20
ATE166390T1 (de) 1998-06-15
GR3027636T3 (en) 1998-11-30
GB9215232D0 (en) 1992-09-02
DK0651806T3 (da) 1999-01-25

Similar Documents

Publication Publication Date Title
ES2053413T3 (es) Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes.
CA2243570A1 (en) Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
RU95115239A (ru) Аналог эритропоэтина
MX9207334A (es) Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
ES2195998T3 (es) Sistemas de expresion de dna basados en alfavirus.
ES2054638T3 (es) Gen codificante de los factores humanos de estimulacion colonial.
CO4480039A1 (es) Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina
NO944245L (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
AR013529A1 (es) Rantes amino-terminalmente truncado, moleculas de adn, vector de expresion, celula huesped, proceso recombinante para prepararlo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende.
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
ES2186671T3 (es) Adn del sitio de integracion del virus asociado a adenovirus humano y usos del mismo.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
AR123206A1 (es) Terapia génica
PT652287E (pt) Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina
ES2039239T3 (es) Vacuna contra el virus varicela-zoster.
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
ES2068893T3 (es) Nuevos peptidos, su uso como inmuno-supresores y procedimientos para su preparacion.
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
PT817858E (pt) Preparacoes fotoprotectoras que compreendem derivados de triazina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 651806

Country of ref document: ES